Diabetes Patients Must Guard Against Long-Term Drug Risks
Type 2 diabetes patients face a hard row to hoe. As patients know first-hand, managing diabetes requires careful monitoring of blood glucose levels, diligent lifestyle choices, and appropriate pharmacological and dietary choices. Type 2 diabetes is a 24/7 disease.
A growing number of Type 2 diabetes patients are increasingly realizing that some pharmacological options can be more destructive than ameliorative. In fact, some drugs are dangerous. So dangerous, in fact, that they may cause injury – and give rise to valid legal complaints. That’s certainly the case with Actos (pioglitazone).
When taken for longer than one year, Actos (pioglitazone), a well-known and widely distributed Type 2 diabetes medication, may substantially increase the likelihood that patients develop bladder cancer. The risk is so high that France and Germany have taken decisive action designed to limit the availability of Actos to their markets. And in the United States, the FDA has issued a strongly worded warning that all patients should take under consideration.
Tragically, for a significant number of Type 2 diabetes patients, the FDA’s warning from this summer was too little, too late. They put their trust in the makers of Actos and now face a painful fight with cancer in addition to their diabetes prognosis. If you or a loved one fall into this category, you should speak with the dangerous drug attorneys at Fears Nachawati to find out if your rights have been violated. You free consultation is a phone call away! Just call 1.866.545.8364 or email email@example.com. Let us fight for you!